source
- Tiziana's lower-dose foralumab cuts neuroinflammation in SPMS, but higher dose failsTiziana Life Sciences reported that its intranasal anti‑CD3 antibody, foralumab, lowered a neuroinflammation biomarker in patients with non‑active secondary progressive multiple sclerosis when give…
- Woman travels to Albania for experimental mitochondrial replacement therapy amid global fertility industry concernsA STAT reporter detailed a case of a woman named Heidy Willis who, after multiple failed IVF cycles, sought an experimental fertility option abroad. Willis traveled to Albania to undergo mitochond…